Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Books and Arts
Nature Chemistry 1, 99 (1 May 2009) | doi:10.1038/nchem.184
The insider
Abstract
John LaMattina is the former head of Pfizer's global research and development (R&D) effort, and that may be as much as many people need to know about his book. This is a shame, since most of them could benefit from reading it.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
